Abstract

Histone modifications are associated with distinct transcriptional states, but it is unclear whether they instruct gene expression. To investigate this, we mutate histone H3.3 K9 and K27 residues in mouse embryonic stem cells (mESCs). Here, we find that H3.3K9 is essential for controlling specific distal intergenic regions and for proper H3K27me3 deposition at promoters. The H3.3K9A mutation resulted in decreased H3K9me3 at regions encompassing endogenous retroviruses and induced a gain of H3K27ac and nascent transcription. These changes in the chromatin environment unleash cryptic enhancers, resulting in the activation of distinctive transcriptional programs and culminating in protein expression normally restricted to specialized immune cell types. The H3.3K27A mutant disrupts the deposition and spreading of the repressive H3K27me3 mark, particularly impacting bivalent genes with higher basal levels of H3.3 at promoters. Therefore, H3.3K9 and K27 crucially orchestrate repressive chromatin states at cis-regulatory elements and bivalent promoters, respectively, and instruct proper transcription in mESCs.

In this study, the authors mutate histone H3.3 K9 and K27 residues, demonstrating their importance in maintaining repressive chromatin states at endogenous retrovirus-derived cryptic enhancers and bivalent promoters in mouse embryonic stem cells.

Details

Title
Histone H3.3 lysine 9 and 27 control repressive chromatin at cryptic enhancers and bivalent promoters
Author
Trovato, Matteo 1   VIAFID ORCID Logo  ; Bunina, Daria 2 ; Yildiz, Umut 1   VIAFID ORCID Logo  ; Fernandez-Novel Marx, Nadine 3 ; Uckelmann, Michael 4 ; Levina, Vita 4 ; Perez, Yekaterina 5   VIAFID ORCID Logo  ; Janeva, Ana 3 ; Garcia, Benjamin A. 5   VIAFID ORCID Logo  ; Davidovich, Chen 4   VIAFID ORCID Logo  ; Zaugg, Judith B. 6   VIAFID ORCID Logo  ; Noh, Kyung-Min 3   VIAFID ORCID Logo 

 Genome Biology Unit, European Molecular Biology Laboratory (EMBL), Heidelberg, Germany (GRID:grid.4709.a) (ISNI:0000 0004 0495 846X); Faculty of Biosciences, Collaboration for joint PhD degree between EMBL and Heidelberg University, Heidelberg, Germany (GRID:grid.7700.0) (ISNI:0000 0001 2190 4373) 
 Genome Biology Unit, European Molecular Biology Laboratory (EMBL), Heidelberg, Germany (GRID:grid.4709.a) (ISNI:0000 0004 0495 846X); Structural and Computational Biology Unit, European Molecular Biology Laboratory (EMBL), Heidelberg, Germany (GRID:grid.4709.a) (ISNI:0000 0004 0495 846X) 
 Genome Biology Unit, European Molecular Biology Laboratory (EMBL), Heidelberg, Germany (GRID:grid.4709.a) (ISNI:0000 0004 0495 846X) 
 and EMBL-Australia, Department of Biochemistry and Molecular Biology, Biomedicine Discovery Institute, Faculty of Medicine, Nursing and Health Sciences, Monash University, Clayton, Australia (GRID:grid.1002.3) (ISNI:0000 0004 1936 7857) 
 Washington University School of Medicine, Department of Biochemistry and Molecular Biophysics, St. Louis, USA (GRID:grid.4367.6) (ISNI:0000 0001 2355 7002) 
 Structural and Computational Biology Unit, European Molecular Biology Laboratory (EMBL), Heidelberg, Germany (GRID:grid.4709.a) (ISNI:0000 0004 0495 846X) 
Pages
7557
Publication year
2024
Publication date
2024
Publisher
Nature Publishing Group
e-ISSN
20411723
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
3098954253
Copyright
© The Author(s) 2024. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.